Short Interest in Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Grows By 144.0%

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 12,200 shares, an increase of 144.0% from the December 15th total of 5,000 shares. Based on an average trading volume of 5,300 shares, the days-to-cover ratio is presently 2.3 days.

Clinuvel Pharmaceuticals Stock Performance

Clinuvel Pharmaceuticals stock traded down $0.13 during trading on Tuesday, hitting $6.89. The company’s stock had a trading volume of 28,124 shares, compared to its average volume of 7,805. The stock’s fifty day moving average is $8.17 and its 200 day moving average is $9.16. Clinuvel Pharmaceuticals has a 1-year low of $6.80 and a 1-year high of $11.40.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).